Needham analyst Matt McGinley maintained a Buy rating on Trulieve Cannabis (TCNNF – Research Report) today and set a price target of $47.00. The company's shares closed last Wednesday at $13.60, close to its 52-week low of $12.72. According to TipRanks.com, McGinley is a 4-star analyst with an average return of 14.3% and a 34.0% success rate. McGinley covers the Basic Materials sector, focusing on stocks such as Ascend Wellness Holdings LLC, Green Thumb Industries, and Curaleaf Holdings. Trulieve Cannabis has an analyst consensus of Strong Buy, with a price target consensus of $51.82. See the top stocks recommended by analysts >> Trulieve Cannabis' market cap is currently $2.
https://www.tipranks.com/news/blurbs/needham-thinks-trulieve-cannabis-stock-is-going-to-recover-2?utm_source=advfn.com&utm_medium=referral
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Trulieve Cannabis (QX) Charts.